论文部分内容阅读
目的:探讨临床药师参与危重病药学服务的应用研究。方法:将ICU住院的患者86例随机分为2组,2组治疗前后分别进行APACHEA II评分,一组为药学监护组将评价结果及时反馈给主管医师,并对治疗患者提出相应的药学建议,主管医生皆采纳药学建议,对照组将评价结果及时反馈给主管医师,并对治疗患者提出相应的药学建议,主管医生不采纳或不完全采纳药学建议。对比2组治疗10d前后的APACHEA II评分、ICU住院时间、死亡率。结果:药学监护组治疗前后APACHEA II评分差异具有显著性,对照组治疗前后APACHEA II评分差异也具有显著性,2组治疗前APACHEA II评分差异无显著性。结论:临床药师以APACHEA II评分来评价对危重病患者综合治疗的疗效指标,结合专业知识积极参与危重病患者的治疗,能降低危重病APACHEA II评分,缩短危重病患者在ICU住院时间,提高危重病患者抢救成功率。
Objective: To investigate the application of clinical pharmacists in the pharmacy services of critically ill patients. Methods: Eighty-six patients hospitalized in ICU were randomly divided into two groups. Two groups were evaluated APACHEA II score before and after treatment. One group was evaluated by pharmacy monitoring group and the results were reported to the chief physician in time. Corresponding pharmacological suggestions were given to the patients, The competent doctors adopted the pharmacological suggestions, and the control group timely feedback the evaluation results to the chief physician, and put forward the corresponding pharmacy recommendations for the patients to be treated. The competent doctors did not adopt or did not fully adopt the pharmaceutical recommendations. The APACHEA II scores before and after 10 days of treatment in two groups were compared, and the hospital stay and mortality of ICU were compared. Results: There was significant difference in APACHEA II score before and after treatment between the two groups. The difference of APACHEA II score before and after treatment in the control group was also significant. There was no significant difference in APACHEA II score between the two groups before treatment. Conclusion: The clinical pharmacist evaluated APACHEA II score for comprehensive treatment of critically ill patients, combined with professional knowledge and active participation in the treatment of critically ill patients, can reduce APACHEA II score of critically ill patients, shorten the hospital stay of critically ill patients in the ICU and improve the critical Patient rescue success rate.